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Abstract: During DNA replication many factors can result in DNA replication stress. The DNA
replication stress checkpoint prevents the accumulation of replication stress-induced DNA damage
and the potential ensuing genome instability. A critical role for post-translational modifications,
such as phosphorylation, in the replication stress checkpoint response has been well established.
However, recent work has revealed an important role for transcription in the cellular response to DNA
replication stress. In this review, we will provide an overview of current knowledge of the cellular
response to DNA replication stress with a specific focus on the DNA replication stress checkpoint
transcriptional response and its role in the prevention of replication stress-induced DNA damage.
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1. DNA Replication
The genome must be faithfully replicated in each cell cycle. In eukaryotic cells, to ensure timely
completion of genome duplication, DNA replication is initiated in S phase from multiple origins
throughout the genome. To prevent genome instability, DNA must be replicated once and only once
during each cell cycle. Re-replication can result in gene amplification and DNA damage [1] but is
prevented by a variety of mechanisms. The control of origins of replication has been reviewed previously
in [1]. In short, DNA replication is tightly regulated via two distinct and temporally separated stages.
Origins are ”licensed” in G1 phase when Cyclin-Dependent Kinase (CDK) activity is low and replication
is initiated (origin firing) from these licensed origins in the subsequent S phase, when CDK activity
accumulates [2]. Licensing in G1 phase, when CDK activity is low, defines potential sites of replication
initiation and occurs through the loading of the Mcm2–7 helicase by the Origin Recognition Complex
(ORC, Orc1-6), Cdc6 and Cdt1, forming the pre-Replicative Complex (pre-RC) [1,3–5]. The firing of
this Mcm2–7 double hexamer is prevented in G1 by low CDK activity. In each G1 phase many more
origins are licensed than are used in the following S phase [6]. This results in dormant origins that are
not fired in an unperturbed cell cycle, but are important for the response to DNA replication stress [7–9].
Dormant origins are disassembled by passive replication in S phase, preventing their activation and
re-replication [10].
Progression into S phase requires high CDK activity, which triggers firing of origins and replication
initiation. Components of the pre-RC are phosphorylated by the Dbf4-dependent kinase (DDK or Cdc-Dbf4
complex) and Cyclin/CDKs [11,12]. This allows the recruitment of Cdc45, GINS complex, RECQL4 (Sld2
in yeast) and Mcm10, forming the Cdc45/Mcm2–7/GINS (CMG) complex. CDK phosphorylation of
Treslin (Sld3 in yeast) and its subsequent interaction with TopBP1 (Dbp11 in yeast) and the CMG complex
activates the CMG complex. This initiates replication bidirectionally, with each Mcm2–7 hexamer forming
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a replication fork and unwinding DNA outwards from the origin [13]. The replication fork is a structure
containing the DNA helicase, DNA polymerases, proliferating cell nuclear antigen (PCNA), checkpoint
mediators and other proteins. The process of DNA replication requires the exposure of short stretches of
single-stranded DNA (ssDNA) between the helicase and lagging-strand polymerase, which is protected
by Replication Protein A (RPA), a ssDNA binding protein [14].
Re-licensing, and therefore potential re-replication, is prevented in S phase by a number of
mechanisms. Assembly of new pre-RCs is prevented by phosphorylation of pre-RC components, due to
high Cyclin/CDK levels in S phase [15]. In metazoans, Geminin also binds to the pre-RC component
Cdt1, further preventing new pre-RC formation [16]. This inhibition is relieved in the following G1
phase by anaphase promoting complex/cyclosome-dependent (APC/C-dependent) degradation of
Cyclins and Geminin [7]. Cullin-based E3 ubiquitin ligase activity also targets Cdt1 and Orc1 for
degradation to prevent re-licensing and re-replication [17,18].
2. DNA Replication Stress
The slowing down or stalling of replication forks and exposure of extended lengths of ssDNA,
known as DNA replication stress [19], can generate DNA damage. Stalled replication forks can result
in inappropriate intermediate structures, which must be resolved to prevent DNA damage and allow
completion of DNA replication [20]. In addition, stalled forks can collapse after prolonged periods of
stalling, resulting in the dissociation of the replisome complex from DNA [21]. Collapsed forks cannot
reinitiate replication and nearby dormant origins must fire to complete DNA replication. The slow
progression of replication forks and the ensuing checkpoint-dependent global inhibition of origin
firing increases the time required for genome duplication [22]. The end of S phase must therefore be
delayed to ensure that all DNA is replicated before the cell enters mitosis.
DNA replication stress can be induced by oncogene activation or tumour-suppressor inactivation.
This oncogene-induced replication stress has been extensively reviewed previously [23–25].
Oncogene-induced replication stress has recently been proposed as a hallmark of cancer as a very early
event in tumourigenesis [26–29]. Oncogene-induced replication stress is thought to induce DNA damage,
with the DNA damage response (reviewed in [30,31]) acting as an initial barrier to tumourigenesis
through oncogene-induced senescence or apoptosis [25,32,33]. Replication stress-induced DNA damage
is thought to drive mutations that bypass the DNA damage checkpoint and therefore allow continued
tumour progression [25]. As such, oncogene-induced replication stress has a key role in the evolution
of cancer [24] and understanding the response to replication stress has important implications in
enhancing our knowledge of cancer development.
We will now summarise the key causes of DNA replication stress, with reference to how
oncogene-induced replication stress may act through these mechanisms where appropriate.
2.1. DNA Characteristics
DNA replication stress can be caused by particular DNA sequences that are inherently difficult to
replicate [34]. Repeats (dinucleotide, trinucleotide, inverted or tandem) and other sequences can form
secondary DNA structures, such as G-quadruplexes, hairpins and z-DNA, which can block replication
fork progression [20,35]. Replication through repeats can also induce slippage and subsequent repeat
expansion [36]. Areas of the genome containing low origin density can also be inherently difficult
to replicate, due to a lack of dormant origins available to rescue stalled forks. Sites of the genome
displaying high rates of replication fork stalling and breakage, even following mild replication stress,
are known as Common Fragile Sites (CFSs). CFSs show high levels of DNA double-strand breaks
(DSBs) and chromosome rearrangements. In early tumourigenesis, these CFSs are frequently the sites
of allelic imbalances [26,27]. Although the exact cause of CFS is under debate, it is likely to be due to
some or all of the characteristics described above [37,38].
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2.2. Obstructions to Replication Fork Progression
Proteins tightly bound to DNA can obstruct replication fork progression, resulting in replication
stress. DNA is packaged into chromatin and is therefore tightly associated with histone proteins.
Heterochromatic regions show increased levels of DNA damage, suggesting that chromatin state
can affect DNA replication [39,40]. Other proteins, such as the pre-RC at dormant origins and the
kinetochore at centromeres, must be tightly bound to DNA for their function but this can obstruct
replication forks and cause topological and replication stress [41,42]. In the case of Replication Fork
Barriers (RFBs), proteins are recruited to DNA to deliberately stall replication forks; these barriers
are often unidirectional and prevent collisions between replication forks and transcriptional bubbles,
discussed below [43]. Replication fork progression can also be halted by bulky lesions formed by
DNA damage. The effects of DNA damage on replication will vary depending on the particular lesion.
DNA damage and its effects on replication has been extensively reviewed previously [20,31,44].
2.3. Replication and Transcription Collisions
Replication forks and transcriptional bubbles move along the same template and can therefore
collide. These collisions can generate topological stress [41], thereby causing a slowing down or
stalling of replication forks, i.e., DNA replication stress. Collisions between replication forks and
transcriptional bubbles can result in the formation of R-loops [19,45]. R-loops are RNA:DNA hybrids
formed between nascent RNA transcripts and one DNA strand, with the other DNA strand excluded as
ssDNA. R-loops can hinder replication fork progression, expose vulnerable ssDNA and may result in
DSBs following transcription-coupled nucleotide excision repair [46]. Spatial and temporal separation
of replication and transcription can reduce collisions, but cannot completely prevent them, especially
in long or actively transcribed genes [45]. Replication and transcription collisions are thought to be
an important mechanism of oncogene-induced replication stress. Activation of the oncogene Cyclin
E increases the rates of replication initiation. This misregulation of the replication programme is
thought to result in increased replication and transcription collisions, resulting in replication stress [47].
Overexpression of another oncogene, HRASV12, instead increases transcription levels to increase the
frequency of collisions and cause replication stress [48].
2.4. Loss of Regulation of DNA Replication
Components essential for DNA replication must be present at sufficient levels to support replication
at all forks. Depletion of essential components causes replication forks to stall. Most notably, the levels
of the four dinucleotide triphosphates (dNTPs) must be sufficient, their levels are primarily controlled
by ribonucleotide reductase (RNR) enzyme activity [49]. Increased replication initiation, for example
following Cyclin E activation, depletes pools of dNTPs and causes stress, this can be rescued with the
addition of exogenous nucleosides [50].
As well as replication component deregulation, loss of control of DNA replication initiation can also
cause replication stress, through either increasing or decreasing the frequency of replication initiation.
Oncogene activation can drive S phase entry, thereby shortening G1 phase and reducing the number
of origins licensed, as seen for Cyclin E [51,52]. Fewer licensed origins or a reduction in limiting
firing factors results in less replication initiation in S phase. This forces each fork to travel further
to complete genome duplication and is thought to increase the probability of fork stalling and cells
entering mitosis without a fully duplicated genome [23]. Fewer licensed origins also means a reduction
in dormant origins that are able to rescue stalled replication forks [8]. A number of firing factors are
limiting for replication initiation and so increases in protein levels, as is often seen in cancer, can
result in increased replication initiation and can disrupt the temporal pattern of origin firing [53].
Activation of the oncogenes Cyclin E or c-Myc can also cause increased and deregulated replication
initiation [47,54]. In addition to increasing replication and transcription collisions, as discussed above,
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increased replication initiation may deplete essential replication factors, such as dNTPs [50], both of
these cause replication stress.
Re-replication can also occur if regulatory mechanisms fail and allow licensing of replicated DNA
in S phase, as is seen following overexpression of Cdt1 or Cdc6 [55]. Re-replication results in gene
amplifications and genome instability [56]. If re-replication is infrequent it can cause replication stress
by increasing the probability of fork stalling due to the large distance between re-replication origins
and a lack of converging forks to rescue replication. Re-replication may also cause replication stress by
depleting replication components and increasing collisions between replication and transcription.
Activation of oncogenes or inactivation of tumour suppressors often deregulates the CDK-pRB-E2F
pathway [57], therefore driving unscheduled S phase entry. This uncontrolled proliferation is thought
to induce replication stress through many of the mechanisms discussed, including deregulation of
replication origin licensing and firing, exhaustion of replicative factors and increasing replication and
transcription collisions [23,47,50,55,58].
3. DNA Replication Stress Checkpoint Response
In order to tolerate DNA replication stress, the cell has evolved a checkpoint response, conserved
from yeast to man, which prevents DNA damage and genome instability [59]. The checkpoint response
is triggered by the extended lengths of ssDNA exposed during replication stress, likely due to continued
helicase action once the polymerase has stalled [60]. The cellular response to DNA replication stress
has been extensively reviewed previously [7,19,20,59,61–65]. ssDNA is bound by a ssDNA binding
protein, which protects vulnerable ssDNA and recruits the checkpoint sensor kinase; in mammalian
cells these proteins are Replication Protein A (RPA) and ATR (Ataxia Telangiectasia and Rad3-related
protein), respectively [14,66,67]. ATRIP (ATR Interacting Protein) is recruited with ATR [68]. Rad17 is
also recruited, which loads the 9-1-1 complex, which recruits TopBP1 to fully activate ATR [63,69,70].
ATR is a serine/threonine kinase of the PI-3-like kinase family that phosphorylates, among other
targets, the checkpoint effector kinase Chk1 [71,72], as summarised in Figure 1. Replication stress
primarily induces this ATR-Chk1 pathway, whilst the response to DNA DSBs mainly depends on
ATM-Chk2 signalling. However, crosstalk between the two pathways is seen and ATR and Chk1
can have distinct and independent roles in the DNA replication stress checkpoint response [73–75].
Once activated, Chk1 phosphorylates a wide range of targets, altering their level and activity, thereby
activating the checkpoint functions discussed below.
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To  ensure DNA  replication  is  completed  before  a  cell  enters mitosis,  the  replication  stress 
checkpoint  arrests  the  cell  cycle  by  inhibiting  CDK  activity.  CDK  activity  is  constrained  by 
Wee1‐dependent phosphorylation [76], which is removed by the Cdc25 phosphatase. Chk1 acts to 
Figure 1. DNA replication stress is the slo ing do n or stalling of replication forks, which exposes
single-stranded DNA (ssDNA). ssDNA is bound by Replication Protein A (RPA), which recruits
proteins to the stalled fork (recruitment shown with black arrows). This activates the sensor kinase
Ataxia Telangiectasia and Rad3-related protein (ATR), which phosphorylates and activates the effector
kinase Chk1. Chk1 phosphorylates a wide range of targets in the cell to carry out the DNA replication
stress checkpoint functions shown.
3.1. Cell Cycle Arrest
To ensure DNA replication is completed before a cell enters mitosis, the replication stress checkpoint
arrests the cell cycle by inhibiting CDK activity. CDK activity is constrained by Wee1-dependent
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phosphorylation [76], which is removed by the Cdc25 phosphatase. Chk1 acts to increase Wee1
activity and targets Cdc25 for Ubiquitin-dependent degradation and therefore increases CDK inhibitory
phosphorylation, thereby arresting the cell cycle [63,77].
3.2. Stalling and Stabilising Replication Forks
Under conditions of replication stress in which obstructions or depletion of key components
may stall replication forks, other ongoing replication forks must be stalled in a checkpoint-dependent
manner to prevent further replication stress or DNA damage [20,78]. Allowing replication to continue
could further deplete replication components or expose such high amounts of ssDNA that RPA
cannot protect all vulnerable ssDNA and replication catastrophe results [66]. The checkpoint can also
upregulate RNR activity to increase the levels and prevent exhaustion of dNTPs [62]. To prevent the
dissociation of the replisome and the formation of aberrant DNA intermediates, stalled forks must be
stabilised in a process dependent on Chk1 [62,79–81]. In order to stabilise stalled replication forks, a fork
protection complex is formed containing factors such as Rad51, Fanconi Anemia Complementation
Group D2 (FANCD2) [82], PCNA [31], Cdc7 [83,84], Timeless and Tipin [78]. Formation of this complex
is thought to be essential for stalling and stabilising replication forks.
3.3. Control of Origin Firing
The DNA replication stress checkpoint also regulates the firing of replication origins. ATR and
Chk1 prevent new replication factories from forming and therefore inhibit late origin firing, directing
replication components to sections of the genome already undergoing replication [22]. In contrast to the
global inhibition of origin firing, dormant origins local to stress are fired to complete replication. This is
thought to be stochastic firing of dormant origins, which due to fork stalling have not been passively
replicated and disassembled [10,22]. Together these mechanisms ensure that replication is completed
in regions experiencing stress, but no further forks are put at risk of stalling in unreplicated regions.
3.4. Replication Restart
Following the resolution of replication stress, DNA replication must be completed through
a number of different replication restart mechanisms, discussed in detail in [21,85]. Following short
periods of stress, a stalled fork may be restarted via remodelling by helicases. Replication can also
be restarted directly from an intact but stalled replication fork in a process dependent on Rad51 and
X-Ray Repair Cross Complementing 3 (XRCC3), but not involving Homologous Recombination [79].
This process is thought to involve Rad51 coating ssDNA at stalled forks and mediating strand invasion,
which allows replication restart. Forks collapse after longer periods of stress and can be processed into
fork-associated DSBs [86]. This then requires repair mechanisms such as Homologous Recombination
and the local new firing of dormant origins to complete DNA replication.
4. The Transcriptional Response to DNA Replication Stress
The role of post-translational modifications in regulating and coordinating the response to
DNA replication stress has been widely studied [87,88]. Phosphorylation is a key element of the
checkpoint response through ATR and Chk1 kinase activity, but ubiquitination and sumolation are
also important [89]. However, until recently the role of transcription in the Replication Stress Response
(RSR) was largely unknown. Initially the response to replication stress, including the transcriptional
response, was considered together with the response to DNA damage and collectively named the
DNA Damage Response (DDR). However, it has become increasingly clear that these represent
independent responses, in signalling, function and outcome, prompting the authors in a recent
review to use the subheading “The RSR: time to fly solo from the DDR” [90]. In line with this, work
carried out in the fission yeast Schizosaccharomyces pombe established a transcriptional response that
is specific to replication stress. This work showed that G1/S cell-cycle-regulated transcription is
maintained in response to replication stress [91–96]. Interestingly, this is a specific function in the
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response to replication stress as G1/S transcription is instead inactivated in response to DNA damage,
in a checkpoint-dependent manner [97,98]. Subsequent work in the budding yeast Saccharomyces
cerevisiae [99,100] and human cells [101] established that this transcriptional response to replication
stress is conserved from yeast to man [61]. G1/S transcription is a wave of transcription encoding many
components required in S phase, such as those required for DNA replication and repair. Activation of
G1/S transcription in G1 phase drives cell cycle entry and transcription is subsequently repressed
upon S phase entry. G1/S transcription encodes its own repressor, setting up a negative feedback loop
to turn off transcription [101,102]. In response to DNA replication stress, G1/S cell cycle transcription
is maintained through the checkpoint-dependent phosphorylation and inhibition of this repressor,
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Figure 2. In the response to DNA replication stress the checkpoint effector kinase inactivates a repressor,
resulting in sustained G1/S cell cycle transcription. This transcriptional response has a key role in the
tolerance to DNA replication stress. This response is conserved from yeast to man, with the ammalian
names shown here.
4.1. Role of the Replication Stress Transcriptional Response
The conservation of this transcriptional response and its regulatory mechanism suggests
an important role in the cellular response to DNA replication stress. However, in budding yeast
active protein synthesis is not required for cell viability following replication stress [103], suggesting
a non-essential role for the transcriptional response. In contrast, in human cells maintaining G1/S
transcription is a key element of the checkpoint response [101,104]. In mammalian cells G1/S cell cycle
transcription is controlled by the E2F family of transcription factors. E2F-dependent transcription
during G1 depends on the E2F1-3 transcriptional activators, whereas inactivation during S phase
depends on the E2F target and transcriptional repressor E2F6 [105–107]. In response to replication
stress the checkpoint protein kinase Chk1 maintains transcription via phosphorylation and inactivation
of E2F6 [101]. This transcriptional response is required in mammalian cells for an efficient DNA
replication stress checkpoint to prevent DNA damage and genome instability [104].
Stress responses generally induce the transcription of a separate gene network [108].
The transcriptional response to replication stress, where an ongoing transcriptional network is
maintained, is therefore atypical. Key DNA replication control proteins and checkpoint effector proteins
are E2F targets and are therefore expressed during the G1 to S transition. Recent work in mammalian
cells reveals that many of these proteins have short half-lives; therefore, during a replication stress
checkpoint cell cycle arrest, sustained E2F-dependent transcription is required to maintain the levels
of these proteins [104]. In some cases, E2F-dependent transcription is also required for up-regulation
of checkpoint effector proteins. Sustained E2F-dependent transcription and the resulting maintenance
of protein levels is required for key checkpoint functions, including the stalling and stabilisation of
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replication forks, the formation of the protective fork complex and the resolution of stalled forks once
the stress has been relieved. However, this transcriptional response is not seen to have a role in arresting
the cell cycle. Importantly, sustained E2F-dependent transcription is sufficient to form a protective
fork complex, allow the restart of DNA replication following stress and prevent DNA damage in
checkpoint-compromised conditions [104]. The transcriptional response to DNA replication stress is
therefore required and sufficient for key functions of the checkpoint response to prevent DNA damage
and allow cell viability. The number of E2F targets needed to be maintained for an efficient checkpoint
response remains unknown. Specific E2F targets, such as Chk1 and RRM2, have important roles in
the checkpoint response and have been proposed as “replication stress buffers” [24]. Up-regulation
of these proteins is protective in checkpoint-compromised and oncogenic mouse models [109,110].
Whilst it is unlikely that sustaining the expression of one specific E2F target alone is sufficient to prevent
replication stress-induced DNA damage, the actual number of E2F targets involved remains unknown.
5. Regulation of the Transcriptional Response
Sustained E2F-dependent transcription has an essential role in the DNA replication stress
checkpoint response. However, this transcriptional response must be tightly regulated to prevent
damaging effects. Inappropriate expression of individual E2F targets, including Cyclin E, Cdc6 and
Cdt1, causes DNA replication stress and genome instability [47,55,111]. In addition, maintaining
E2F-dependent transcription during S phase would result in increased transcription of many targets,
which is likely to increase the chance of collisions between replication forks and transcriptional bubbles.
5.1. Confining the Transcriptional Response to Replication Stress
The transcriptional response to DNA replication stress involves the inactivation of a negative
feedback loop. Interestingly, this molecular mechanism is used in several transcriptional responses to
genotoxic stress. In budding yeast, DNA replication stress also results in Dun1-dependent inactivation of
a negative feedback loop involving the repressor Crt1 [112]. This primarily induces RNR genes involved
in tolerance to DNA replication stress; however, this transcriptional response is less well-studied in
mammalian cells. The mammalian homologue Rfx1 is also regulated by a negative feedback loop with
DNA replication stress inactivating Rfx1, resulting in Rfx1 and RRM2 up-regulation [113], however
the importance of this for replication stress tolerance is not known. Although increased RRM2 levels
are protective in ATR mutant mice [110], work has indicated that UV-irradiated mammalian cells do
not strongly increase dNTP levels [114]. Regulation of a negative feedback loop is also seen in the
SOS response in Escherichia coli involving the repressor LexA [115]. During recovery from the DNA
damage checkpoint response, regulation of transcription is also mediated via a negative feedback loop,
involving Mdm2 and p53 [116,117]. This network wiring, with the repressors having the capacity to
repress their own expression, would ensure the fast inactivation of transcription during recovery from
the genotoxic stress, Figure 3.
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of  E2F  targets  needed  to  be maintained  for  an  efficient  checkpoint  response  remains  unknown. 
Specific E2F targets, such as Chk1 and RRM2, have important roles in the checkpoint response and 
have been proposed as “replication stress buffers” [24]. Up‐regulation of these proteins is protective 
in  checkpoint‐compromised  and  oncogenic  mouse  models  [109,110].  Whilst  it  is  unlikely  that 
sustaining  the  expression  of  one  specific  E2F  target  alone  is  sufficient  to  prevent  replication 
stress‐induced DNA damage, the actual number of E2F targets involved remains unknown. 
5. Regulation of the Transcriptional Response 
Sustained  E2F‐dependent  transcription  has  an  essential  role  in  the  DNA  replication  stress 
checkpoint response. However,  this  transcriptional response must be  tightly regulated  to prevent 
damaging effects. Inappropriate expression of individual E2F targets, including Cyclin E, Cdc6 and 
Cdt1,  causes DNA  replication  stress  and genome  instability  [47,55,111].  In  addition, maintaining 
E2F‐dependent transcription during S phase would result in increased transcription of many targets, 





to  genotoxic  stress.  In  budding  yeast,  DNA  replication  stress  also  results  in  Dun1‐dependent 
inactivation of a negative feedback loop involving the repressor Crt1 [112]. This primarily induces 
RNR genes involved in tolerance to DNA replication stress; however, this transcriptional response is 
less well‐studied  in mammalian  cells.  The mammalian  homologue  Rfx1  is  also  regulated  by  a 
negative feedback loop with DNA replication stress inactivating Rfx1, resulting in Rfx1 and RRM2 




During  recovery  from  the DNA damage  checkpoint  response,  regulation  of  transcription  is  also 
mediated via a negative  feedback  loop,  involving Mdm2 and p53  [116,117]. This network wiring, 





allow  for  rapid  down‐regulation  of  transcription  and  fast  changes  in  the  proteome  during  the 
recovery from the stress response. 
Figure 3. Schematic showing a general network wiring consisting of a stress response inhibiting a
negative feedback loop and a repressor with the capacity to repress its own transcription. This would
allow for rapid down-regulation of transcription and fast changes in the proteome during the recovery
from the stress response.
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The conservation of this mechanism suggests that these DNA damage and replication
stress-induced transcriptional responses may be deleterious once the problems have been resolved.
Although the exact defects remain to be established, data suggests that persistent expression of G1/S
targets during S phase results in genome instability in both yeast and mammalian cells ([102,118]
and unpublished data). This suggests an important role for the repression of G1/S transcription
outside of the G1 to S phase transition and, perhaps, after recovery from DNA replication stress.
In mammalian cells, there is evidence of checkpoint-dependent degradation of checkpoint effector
proteins such as Chk1 [119,120], but how widely this mechanism is used by the cell remains to be
determined. This additional level of regulation would further ensure that checkpoint-dependent gene
expression is turned off once the checkpoint has been satisfied. The combination of this transcriptional
network inactivation, short half-lives and checkpoint-dependent degradation would mean rapid
changes in the proteome to inactivate the checkpoint response. Future research will reveal whether
rapid down-regulation of DNA structure checkpoint-dependent gene expression is generally important
for the maintenance of genome stability.
5.2. DNA Replication Restart
Following checkpoint inactivation, DNA replication must be restarted; the mechanism signalling
this has not been fully established [85,121]. The βTrCP-dependent degradation of Claspin is required
for efficient termination of Chk1-dependent checkpoint signalling and subsequent recovery of cell
cycle progression [122,123]. Phosphatase activity can also reverse checkpoint signalling and this is
a key mechanism required for replication fork restart [124,125]. One could speculate that the particular
transcriptional response to replication stress, where gene expression is maintained, could have an
important contribution to checkpoint recovery. A combination of sustained transcription and proteins
with short half-lives would result in high turnover rates. Therefore, proteins post-translationally
modified by the checkpoint would be replaced by new and unmodified proteins as soon as the
checkpoint is satisfied. This could act as a robust inactivation of checkpoint signalling in order to allow
and signal for DNA replication restart. Enzymes, such as phosphatases, have some role in this checkpoint
inactivation and recovery [124,125]. However, a mechanism relying on turnover rates may have
a number of advantages. It would be a widespread mechanism to quickly replace post-translationally
modified proteins without the need for individual enzymes to remove each type of post-translational
modification and could therefore be a faster and more robust way of removing checkpoint-dependent
modifications. Checkpoint inactivation dependent on inherent degradation could prevent indefinite
checkpoint activity that would be detrimental for the cell. In addition, as discussed above, the response
containing a repressor poised to function as soon as checkpoint signalling is inactivated would ensure
the fast inactivation of further checkpoint signalling. Importantly, this suggested mechanism would
also directly link checkpoint inactivation and DNA replication restart.
6. The Replication Stress Transcriptional Response and Oncogenic Activity
Maintenance of E2F-dependent transcription in response to DNA replication stress is important
to prevent replication stress-induced DNA damage. However, increased E2F activity is thought
to be a driving force in causing oncogene-induced replication stress. E2F-dependent transcription
is deregulated following activation of many oncogenes, such as Myc, Ras and Cyclin/CDKs,
or inactivation of some tumour suppressors, such as CDK Inhibitors and pRb, which all regulate the
signalling pathway upstream of E2F [57,106,107,126]. This deregulation of E2F-dependent transcription,
which controls the G1 to S phase transition, drives unscheduled S phase entry and uncontrolled
proliferation [51]. As discussed previously, this uncontrolled proliferation is thought to result in
oncogene-induced replication stress through a number of possible mechanisms. In the context of
oncogene-induced replication stress, E2F-dependent transcription is required to both drive and tolerate
replication stress [104]. This dual role creates a likely increased dependence on E2F activity in cancer
cells, Figure 4. Cancer cells experiencing high levels of replication stress are expected to require much
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higher levels of E2F activity and checkpoint function compared to normal cells. This mechanism













The  identification of a  transcriptional  response  to DNA  replication stress  [91–96,99–101] and 
understanding its key role in the checkpoint response [104] opens up possible new areas of research 
[127]. Understanding the complex interactions between transcription, translation, post‐translational 
modifications  and  degradation  rates, which  together  control  the  activity  of  checkpoint  effector 
proteins, would enhance our knowledge of the DNA replication stress checkpoint. This integrated 













Figure 4. any oncogenes deregulate E2F activity, thereby driving S phase entry and uncontrolled
proliferation, resulting in oncogene-induced replication stress and DNA da age. The DNA da age
response acts as an initial barrier to tumourigenesis, but replication stress causes genome instability
driving mutations that bypass the DNA damage checkpoint. However, E2F activity is also required for
tolerance to oncogene-induced replication stress to prevent DNA damage.
. t ti
identification of a transcriptional response to DNA replication tress [91–96,99–101]
a understanding its key rol in the checkpoi t response [104] opens up possible new areas
of research [127]. Und rstanding the omplex int ractions between transcription, translation,
post-translational modific ti s nd degradation rates, which together c ntrol the activity f
checkpoint effector proteins, would enhance our knowledge of the DNA replicatio stress checkpoint.
This integrated network wiring could all w the cell to quickly re-adjust the pr teome once the stress has
been r solved. This may be relevant to other sig alling pathways, in particular, other stress responses.
t ill i t t t t li t t t l t li ti t i t f
t t , t - l ti f t l tr ri ti l t r . i l i t t
to potentially exploit this tolerance mechanism i cancer treatment. Si ultaneously targeting
the tra scriptional tolerance mech ism to replication stress and DNA repair mechanisms ay be very
effective to prevent continued proliferation of ncogenic cells. Ov rall, transcription h s only recently
been identified to have a k y r le in tolerating DNA replication stress, which provides interesting new
av nues of research to fully und rstand and exploit the DNA replication stress check oint.
Genes 2017, 8, 92 10 of 15
Acknowledgments: Anna E. Herlihy and Robertus A.M. de Bruin are funded by Robertus A.M. de Bruin’s Cancer
Research UK Programme Foundation Award and the MRC (award code MC_U12266B). Costs for open access are
covered by UCL Open Access.
Author Contributions: Anna E. Herlihy and Robertus A.M. de Bruin wrote the review. This review was adapted
from text originally prepared for Anna E. Herlihy’s thesis.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Fragkos, M.; Ganier, O.; Coulombe, P.; Méchali, M. DNA replication origin activation in space and time.
Nat. Rev. Mol. Cell Biol. 2015, 16, 360–374. [CrossRef] [PubMed]
2. Yeeles, J.T.P.; Deegan, T.D.; Janska, A.; Early, A.; Diffley, J.F.X. Regulated eukaryotic DNA replication origin
firing with purified proteins. Nature 2015, 519, 431–435. [CrossRef] [PubMed]
3. Woo, R.A.; Poon, R.Y.C. Cyclin-dependent kinases and S phase control in mammalian cells. Cell Cycle 2003,
2, 316–324. [CrossRef] [PubMed]
4. Cook, J.G.; Park, C.-H.; Burke, T.W.; Leone, G.; DeGregori, J.; Engel, A.; Nevins, J.R. Analysis of Cdc6 function
in the assembly of mammalian prereplication complexes. Proc. Natl. Acad. Sci. USA 2002, 99, 1347–1352.
[CrossRef] [PubMed]
5. Rialland, M.; Sola, F.; Santocanale, C. Essential role of human CDT1 in DNA replication and chromatin
licensing. J. Cell Sci. 2002, 115, 1435–1440. [PubMed]
6. Cayrou, C.; Coulombe, P.; Vigneron, A.; Stanojcic, S.; Ganier, O.; Peiffer, I.; Rivals, E.; Puy, A.; Laurent-Chabalier, S.;
Desprat, R.; et al. Genome-scale analysis of metazoan replication origins reveals their organization in specific but
flexible sites defined by conserved features. Genome Res. 2011, 21, 1438–1449. [CrossRef] [PubMed]
7. Yekezare, M.; Gómez-González, B.; Diffley, J.F.X. Controlling DNA replication origins in response to DNA
damage - inhibit globally, activate locally. J. Cell Sci. 2013, 126, 1297–1306. [CrossRef] [PubMed]
8. Blow, J.J.; Ge, X.Q.; Jackson, D.A. How dormant origins promote complete genome replication. Trends Biochem. Sci.
2011, 36, 405–414. [CrossRef] [PubMed]
9. Ge, X.Q.; Jackson, D.A.; Blow, J.J. Dormant origins licensed by excess Mcm2–7 are required for human cells
to survive replicative stress. Genes Dev. 2007, 21, 3331–3341. [CrossRef] [PubMed]
10. Santocanale, C.; Sharma, K.; Diffley, J.F.X. Activation of dormant origins of DNA replication in budding
yeast. Genes Dev. 1999, 13, 2360–2364. [CrossRef] [PubMed]
11. Larasati; Duncker, B. Mechanisms Governing DDK Regulation of the Initiation of DNA Replication. Genes
2016. [CrossRef] [PubMed]
12. Labib, K. How do Cdc7 and cyclin-dependent kinases trigger the initiation of chromosome replication in
eukaryotic cells? Genes Dev. 2010, 24, 1208–1219. [CrossRef] [PubMed]
13. Martinez, M.P.; Jones, J.M.; Bruck, I.; Kaplan, D.L. Origin DNA Melting-An Essential Process with Divergent
Mechanisms. Genes 2017. [CrossRef] [PubMed]
14. Zou, Y.U.E.; Liu, Y.; Wu, X.; Shell, S.M. Functions of Human Replication Protein A (RPA): From DNA
Replication to DNA Damage and Stress Responses. J. Cell. Physiol. 2006, 208, 267–273. [CrossRef] [PubMed]
15. Nguyen, V.Q.; Co, C.; Li, J.J. Cyclin-dependent kinases prevent DNA re-replication through multiple
mechanisms. Nature 2001, 411, 1068–1073. [CrossRef] [PubMed]
16. Wohlschlegel, J.A.; Dwyer, B.T.; Dhar, S.K.; Cvetic, C.; Walter, J.C.; Dutta, A. Inhibition of Eukaryotic DNA
Replication by Geminin Binding to Cdt1. Science 2000, 290, 2309–2312. [CrossRef] [PubMed]
17. Li, X.; Zhao, Q.; Liao, R.; Sun, P.; Wu, X. The SCFSkp2 ubiquitin ligase complex interacts with the human
replication licensing factor Cdt1 and regulates Cdt1 degradation. J. Biol. Chem. 2003, 278, 30854–30858.
[CrossRef] [PubMed]
18. Méndez, J.; Zou-Yang, X.H.; Kim, S.-Y.; Hidaka, M.; Tansey, W.P.; Stillman, B. Human Origin Recognition
Complex Large Subunit Is Degraded by Ubiquitin-Mediated Proteolysis after Initiation of DNA Replication.
Mol. Cell 2002, 9, 481–491. [CrossRef]
19. Zeman, M.K.; Cimprich, K. a Causes and consequences of replication stress. Nat. Cell Biol. 2013, 16, 2–9.
[CrossRef] [PubMed]
20. Branzei, D.; Foiani, M. Maintaining genome stability at the replication fork. Nat. Rev. Mol. Cell Biol. 2010, 11,
208–219. [CrossRef] [PubMed]
Genes 2017, 8, 92 11 of 15
21. Petermann, E.; Helleday, T. Pathways of mammalian replication fork restart. Nat. Rev. Mol. Cell Biol. 2010,
11, 683–687. [CrossRef] [PubMed]
22. Ge, X.Q.; Blow, J.J. Chk1 inhibits replication factory activation but allows dormant origin firing in existing
factories. J. Cell Biol. 2010, 191, 1285–1297. [CrossRef] [PubMed]
23. Hills, S.A.; Diffley, J.F.X. DNA Replication and Oncogene-Induced Replicative Stress. Curr. Biol. 2014, 24,
R435–R444. [CrossRef] [PubMed]
24. Lecona, E.; Fernández-Capetillo, O. Replication stress and cancer: It takes two to tango. Exp. Cell Res. 2014,
329, 26–34. [CrossRef] [PubMed]
25. Halazonetis, T.D.; Gorgoulis, V.G.; Bartek, J. An Oncogene-Induced DNA Damage Model for Cancer
Development. Science 2008, 319, 1352–1355. [CrossRef] [PubMed]
26. Bartkova, J.; Horejsí, Z.; Koed, K.; Krämer, A.; Tort, F.; Zieger, K.; Guldberg, P.; Sehested, M.; Nesland, J.M.;
Lukas, C.; et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.
Nature 2005, 434, 864–870. [CrossRef] [PubMed]
27. Gorgoulis, V.; Vassiliou, L.; Karakaidos, P.; Zacharatos, P.; Kotsinas, A.; Liloglou, T.; Venere, M.; DiTullio, R., Jr.;
Kastrinakis, N.; Levy, B.; et al. Activation of the DNA damage checkpoint and genomic instability in human
precancerous lesions. Nature 2005, 434, 907–913. [CrossRef] [PubMed]
28. Macheret, M.; Halazonetis, T.D. DNA Replication Stress as a Hallmark of Cancer. Annu. Rev. Pathol. Mech. Dis.
2015, 10, 425–448. [CrossRef] [PubMed]
29. Tsantoulis, P.K.; Kotsinas, A.; Sfikakis, P.P.; Evangelou, K.; Sideridou, M.; Levy, B.; Mo, L.; Kittas, C.; Wu, X.-R.;
Papavassiliou, A.G.; et al. Oncogene-induced replication stress preferentially targets common fragile sites in
preneoplastic lesions. A genome-wide study. Oncogene 2008, 27, 3256–3264. [CrossRef] [PubMed]
30. Jackson, S.P.; Bartek, J. The DNA-damage response in human biology and disease. Nature 2009, 461,
1071–1078. [CrossRef] [PubMed]
31. Ciccia, A.; Elledge, S.J. The DNA Damage Response: Making It Safe to Play with Knives. Mol. Cell 2010, 40,
179–204. [CrossRef] [PubMed]
32. Bartkova, J.; Rezaei, N.; Liontos, M.; Karakaidos, P.; Kletsas, D.; Issaeva, N.; Vassiliou, L.V.; Kolettas, E.;
Niforou, K.; Zoumpourlis, V.C.; et al. Oncogene-induced senescence is part of the tumorigenesis barrier
imposed by DNA damage checkpoints. Nature 2006, 444, 633–637. [CrossRef] [PubMed]
33. Di Micco, R.; Fumagalli, M.; Cicalese, A.; Piccinin, S.; Gasparini, P.; Luise, C.; Schurra, C.; Garre, M.;
Nuciforo, P.G.; Bensimon, A.; et al. Oncogene-induced senescence is a DNA damage response triggered by
DNA hyper-replication. Nature 2006, 444, 638–642. [CrossRef] [PubMed]
34. Wang, G.; Vasquez, K. Effects of Replication and Transcription on DNA Structure-Related Genetic Instability.
Genes 2017. [CrossRef] [PubMed]
35. Mirkin, E.V.; Mirkin, S.M. Replication fork stalling at natural impediments. Microbiol. Mol. Biol. Rev. 2007,
71, 13–35. [CrossRef] [PubMed]
36. Viguera, E.; Canceill, D.; Ehrlich, S.D. Replication slippage involves DNA polymerase pausing and
dissociation. EMBO J. 2001, 20, 2587–2595. [CrossRef] [PubMed]
37. Debatisse, M.; Le Tallec, B.; Letessier, A.; Dutrillaux, B.; Brison, O. Common fragile sites: Mechanisms of
instability revisited. Trends Genet. 2012, 28, 22–32. [CrossRef] [PubMed]
38. Durkin, S.G.; Glover, T.W. Chromosome Fragile Sites. Annu. Rev. Genet. 2007, 41, 169–192. [CrossRef] [PubMed]
39. Szilard, R.K.; Jacques, P.E.; Laramée, L.; Cheng, B.; Galicia, S.; Bataille, A.R.; Yeung, M.; Mendez, M.;
Bergeron, M.; Robert, F.; et al. Systematic identification of fragile sites via genome-wide location analysis of
γ-H2AX. Nat. Struct. Mol. Biol. 2011, 17, 299–305. [CrossRef] [PubMed]
40. Rozenzhak, S.; Mejía-Ramírez, E.; Williams, J.S.; Schaffer, L.; Hammond, J.A.; Head, S.R.; Russell, P. Rad3ATR
decorates critical chromosomal domains with γH2A to protect genome integrity during S-phase in fission
yeast. PLoS Genet. 2010, 6, 1–17. [CrossRef] [PubMed]
41. Keszthelyi, A.; Minchell, N.; Baxter, J. The Causes and Consequences of Topological Stress during DNA
Replication. Genes 2016. [CrossRef] [PubMed]
42. Ivessa, A.S.; Lenzmeier, B.A.; Bessler, J.B.; Goudsouzian, L.K.; Schnakenberg, S.L.; Zakian, V.A.
The Saccharomyces cerevisiae Helicase Rrm3p Facilitates Replication Past Nonhistone Protein-DNA
Complexes. Mol. Cell 2003, 12, 1525–1536. [CrossRef]
43. Lambert, S.; Carr, A.M. Impediments to replication fork movement: Stabilisation, reactivation and genome
instability. Chromosoma 2013, 122, 33–45. [CrossRef] [PubMed]
Genes 2017, 8, 92 12 of 15
44. Branzei, D.; Foiani, M. Regulation of DNA repair throughout the cell cycle. Nat. Rev. Mol. Cell Biol. 2008, 9,
297–308. [CrossRef] [PubMed]
45. Helmrich, A.; Ballarino, M.; Tora, L. Collisions between Replication and Transcription Complexes Cause
Common Fragile Site Instability at the Longest Human Genes. Mol. Cell 2011, 44, 966–977. [CrossRef]
[PubMed]
46. Muñoz, S.; Méndez, J. DNA replication stress: From molecular mechanisms to human disease. Chromosoma
2016. [CrossRef] [PubMed]
47. Jones, R.M.; Mortusewicz, O.; Afzal, I.; Lorvellec, M.; García, P.; Helleday, T.; Petermann, E. Increased
replication initiation and conflicts with transcription underlie Cyclin E-induced replication stress. Oncogene
2013, 32, 3744–3753. [CrossRef] [PubMed]
48. Kotsantis, P.; Silva, L.M.; Irmscher, S.; Jones, R.M.; Folkes, L.; Gromak, N.; Petermann, E. Increased global
transcription activity as a mechanism of replication stress in cancer. Nat. Commun. 2016. [CrossRef] [PubMed]
49. Aye, Y.; Li, M.; Long, M.J.C.; Weiss, R.S. Ribonucleotide reductase and cancer: Biological mechanisms and
targeted therapies. Oncogene 2014, 34, 2011–2021. [CrossRef] [PubMed]
50. Bester, A.C.; Roniger, M.; Oren, Y.S.; Im, M.M.; Sarni, D.; Chaoat, M.; Bensimon, A.; Zamir, G.; Shewach, D.S.;
Kerem, B. Nucleotide deficiency promotes genomic instability in early stages of cancer development. Cell
2011, 145, 435–446. [CrossRef] [PubMed]
51. Resnitzky, D.; Gossen, M.; Bujard, H.; Reed, S.I. Acceleration of the G1/S phase transition by expression of
cyclins D1 and E with an inducible system. Mol. Cell. Biol. 1994, 14, 1669–1679. [CrossRef] [PubMed]
52. Ekholm-Reed, S.; Méndez, J.; Tedesco, D.; Zetterberg, A.; Stillman, B.; Reed, S.I. Deregulation of cyclin E
in human cells interferes with prereplication complex assembly. J. Cell Biol. 2004, 165, 789–800. [CrossRef]
[PubMed]
53. Tanaka, S.; Araki, H. Multiple regulatory mechanisms to inhibit untimely initiation of DNA replication are
important for stable genome maintenance. PLoS Genet. 2011, 7, 1–16. [CrossRef] [PubMed]
54. Dominguez-Sola, D.; Ying, C.Y.; Grandori, C.; Ruggiero, L.; Chen, B.; Li, M.; Galloway, D.A.; Gu, W.;
Gautier, J.; Dalla-Favera, R. Non-transcriptional control of DNA replication by c-Myc. Nature 2007, 448,
445–451. [CrossRef] [PubMed]
55. Liontos, M.; Koutsami, M.; Sideridou, M.; Evangelou, K.; Kletsas, D.; Levy, B.; Kotsinas, A.; Nahum, O.;
Zoumpourlis, V.; Kouloukoussa, M.; et al. Deregulated overexpression of hCdt1 and hCdc6 promotes
malignant behavior. Cancer Res. 2007, 67, 10899–10909. [CrossRef] [PubMed]
56. Green, B.M.; Finn, K.J.; Li, J.J. Loss of DNA replication control is a potent inducer of gene amplification.
Science 2010, 329, 943–946. [CrossRef] [PubMed]
57. Chen, H.-Z.; Tsai, S.-Y.; Leone, G. Emerging roles of E2Fs in cancer: An exit from cell cycle control.
Nat. Rev. Cancer 2009, 9, 785–797. [CrossRef] [PubMed]
58. Tuduri, S.; Crabbe, L.; Coquelle, A.; Pasero, P. Does interference between replication and transcription
contribute to genomic instability in cancer cells? Cell Cycle 2010, 9, 1886–1892. [CrossRef] [PubMed]
59. Jossen, R.; Bermejo, R. The DNA damage checkpoint response to replication stress: A Game of Forks.
Front. Genet. 2013. [CrossRef] [PubMed]
60. Byun, T.S.; Pacek, M.; Yee, M.C.; Walter, J.C.; Cimprich, K.A. Functional uncoupling of MCM helicase
and DNA polymerase activities activates the ATR-dependent checkpoint. Genes Dev. 2005, 19, 1040–1052.
[CrossRef] [PubMed]
61. Bertoli, C.; Skotheim, J.M.; de Bruin, R.A.M. Control of cell cycle transcription during G1 and S phases.
Nat. Rev. Mol. Cell Biol. 2013, 14, 518–528. [CrossRef] [PubMed]
62. Zegerman, P.; Diffley, J.F.X. DNA replication as a target of the DNA damage checkpoint. DNA Repair (Amst.)
2009, 8, 1077–1088. [CrossRef] [PubMed]
63. Sørensen, C.S.; Syljuåsen, R.G. Safeguarding genome integrity: The checkpoint kinases ATR, CHK1 and
WEE1 restrain CDK activity during normal DNA replication. Nucleic Acids Res. 2012, 40, 477–486. [CrossRef]
[PubMed]
64. Barnes, R.; Eckert, K. Maintenance of Genome Integrity: How Mammalian Cells Orchestrate Genome
Duplication by Coordinating Replicative and Specialized DNA Polymerases. Genes 2017. [CrossRef]
[PubMed]
65. Branzei, D.; Foiani, M. The checkpoint response to replication stress. DNA Repair (Amst.) 2009, 8, 1038–1046.
[CrossRef] [PubMed]
Genes 2017, 8, 92 13 of 15
66. Toledo, L.I.; Altmeyer, M.; Rask, M.-B.; Lukas, C.; Larsen, D.H.; Povlsen, L.K.; Bekker-Jensen, S.; Mailand, N.;
Bartek, J.; Lukas, J. ATR Prohibits Replication Catastrophe by Preventing Global Exhaustion of RPA. Cell
2013, 155, 1088–1103. [CrossRef] [PubMed]
67. Feng, W. Mec1/ATR, the Program Manager of Nucleic Acids Inc. Genes 2016. [CrossRef] [PubMed]
68. Zou, L.; Elledge, S.J. Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science
2003, 300, 1542–1548. [CrossRef] [PubMed]
69. Zou, L.; Liu, D.; Elledge, S.J. Replication protein A-mediated recruitment and activation of Rad17 complexes.
Proc. Natl. Acad. Sci. USA 2003, 100, 13827–13832. [CrossRef] [PubMed]
70. Kumagai, A.; Lee, J.; Yoo, H.Y.; Dunphy, W.G. TopBP1 activates the ATR-ATRIP complex. Cell 2006, 124,
943–955. [CrossRef] [PubMed]
71. Abraham, R.T. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev. 2001, 15,
2177–2196. [CrossRef]
72. Liu, Q.; Guntuku, S.; Cui, X.S.; Matsuoka, S.; Cortez, D.; Tamai, K.; Luo, G.; Carattini-Rivera, S.; DeMayo, F.;
Bradley, A.; et al. Chk1 is an essential kinase that is regulated by Atr and required for the G2/M DNA
damage checkpoint. Genes Dev. 2000, 14, 1448–1459. [PubMed]
73. Bartek, J.; Lukas, J. Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 2003, 3, 421–429.
[CrossRef]
74. Buisson, R.; Boisvert, J.L.; Benes, C.H.; Zou, L. Distinct but Concerted Roles of ATR, DNA-PK, and Chk1 in
Countering Replication Stress during S phase. Mol. Cell 2015, 59, 1011–1024. [CrossRef] [PubMed]
75. Koundrioukoff, S.; Carignon, S.; Técher, H.; Letessier, A.; Brison, O.; Debatisse, M. Stepwise Activation of the
ATR Signaling Pathway upon Increasing Replication Stress Impacts Fragile Site Integrity. PLoS Genet. 2013.
[CrossRef] [PubMed]
76. McGowan, C.H.; Russell, P. Human Wee1 kinase inhibits cell division by phosphorylating p34cdc2
exclusively on Tyr15. EMBO J. 1993, 12, 75–85. [PubMed]
77. Sørensen, C.S.; Syljuåsen, R.G.; Falck, J.; Schroeder, T.; Rönnstrand, L.; Khanna, K.K.; Zhou, B.B.; Bartek, J.;
Lukas, J. Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing
radiation-induced accelerated proteolysis of Cdc25A. Cancer Cell 2003, 3, 247–258. [CrossRef]
78. Unsal-Kaçmaz, K.; Chastain, P.D.; Qu, P.-P.; Minoo, P.; Cordeiro-Stone, M.; Sancar, A.; Kaufmann, W.K.
The human Tim/Tipin complex coordinates an Intra-S checkpoint response to UV that slows replication fork
displacement. Mol. Cell. Biol. 2007, 27, 3131–3142. [CrossRef] [PubMed]
79. Petermann, E.; Orta, M.L.; Issaeva, N.; Schultz, N.; Helleday, T. Hydroxyurea-stalled replication forks
become progressively inactivated and require two different RAD51-mediated pathways for restart and repair.
Mol. Cell 2010, 37, 492–502. [CrossRef] [PubMed]
80. Lopes, M.; Cotta-Ramusino, C.; Pellicioli, A.; Liberi, G.; Plevani, P.; Muzi-Falconi, M.; Newlon, C.S.; Foiani, M.
The DNA replication checkpoint response stabilizes stalled replication forks. Nature 2001, 412, 557–561.
[CrossRef] [PubMed]
81. Calzada, A.; Hodgson, B.; Kanemaki, M.; Bueno, A.; Labib, K. Molecular anatomy and regulation of a stable
replisome eukaryotic DNA at a paused replication fork. Genes Dev. 2005, 19, 1905–1919. [CrossRef] [PubMed]
82. Lossaint, G.; Larroque, M.; Ribeyre, C.; Bec, N.; Larroque, C.; Décaillet, C.; Gari, K.; Constantinou, A.
FANCD2 Binds MCM Proteins and Controls Replisome Function upon Activation of S Phase Checkpoint
Signaling. Mol. Cell 2013, 51, 678–690. [CrossRef] [PubMed]
83. Yamada, M.; Masai, H.; Bartek, J. Regulation and roles of Cdc7 kinase under replication stress. Cell Cycle
2014, 13, 1859–1866. [CrossRef] [PubMed]
84. Yamada, M.; Watanabe, K.; Mistrik, M.; Vesela, E.; Protivankova, I.; Mailand, N.; Lee, M.; Masai, H.; Lukas, J.;
Bartek, J. ATR–Chk1–APC/C Cdh1-dependent stabilization of Cdc7–ASK (Dbf4) kinase is required for DNA
lesion bypass under replication stress. Genes Dev. 2013, 27, 2459–2472. [CrossRef] [PubMed]
85. Chaudhury, I.; Koepp, D. Recovery from the DNA Replication Checkpoint. Genes 2016. [CrossRef] [PubMed]
86. Hanada, K.; Budzowska, M.; Davies, S.L.; van Drunen, E.; Onizawa, H.; Beverloo, H.B.; Maas, A.; Essers, J.;
Hickson, I.D.; Kanaar, R. The structure-specific endonuclease Mus81 contributes to replication restart by
generating double-strand DNA breaks. Nat. Struct. Mol. Biol. 2007, 14, 1096–1104. [CrossRef] [PubMed]
87. Huen, M.S.Y.; Chen, J. The DNA damage response pathways: At the crossroad of protein modifications.
Cell Res. 2008, 18, 8–16. [CrossRef] [PubMed]
Genes 2017, 8, 92 14 of 15
88. García-Rodríguez, N.; Wong, R.P.; Ulrich, H.D. Functions of Ubiquitin and SUMO in DNA Replication and
Replication Stress. Front. Genet. 2016, 7, 1–28. [CrossRef] [PubMed]
89. Moldovan, G.-L.; Pfander, B.; Jentsch, S. PCNA, the maestro of the replication fork. Cell 2007, 129, 665–679.
[CrossRef] [PubMed]
90. Toledo, L.I.; Murga, M.; Fernandez-Capetillo, O. Targeting ATR and Chk1 kinases for cancer treatment:
A new model for new (and old) drugs. Mol. Oncol. 2011, 5, 368–373. [CrossRef] [PubMed]
91. De Bruin, R.A.M.; Kalashnikova, T.I.; Aslanian, A.; Wohlschlegel, J.; Chahwan, C.; Yates, J.R.; Russell, P.;
Wittenberg, C. DNA replication checkpoint promotes G1-S transcription by inactivating the MBF repressor
Nrm1. Proc. Natl. Acad. Sci. USA 2008, 105, 11230–11235. [CrossRef] [PubMed]
92. Dutta, C.; Patel, P.K.; Rosebrock, A.; Oliva, A.; Leatherwood, J.; Rhind, N. The DNA Replication Checkpoint
Directly Regulates MBF-Dependent G1/S Transcription. Mol. Cell. Biol. 2008, 28, 5977–5985. [CrossRef]
[PubMed]
93. Chu, Z.; Li, J.; Eshaghi, M.; Peng, X.; Karuturi, R.K.M.; Liu, J. Modulation of Cell Cycle–specific Gene
Expressions at the Onset of S Phase Arrest Contributes to the Robust DNA Replication Checkpoint Response
in Fission Yeast. Mol. Biol. Cell 2007, 18, 1756–1767. [CrossRef] [PubMed]
94. Caetano, C.; Klier, S.; de Bruin, R.A.M. Phosphorylation of the MBF repressor Yox1p by the DNA replication
checkpoint keeps the G1/S cell-cycle transcriptional program active. PLoS ONE 2011, 6, e17211. [CrossRef]
[PubMed]
95. Ivanova, T.; Gómez-Escoda, B.; Hidalgo, E.; Ayté, J. G1/S transcription and the DNA synthesis checkpoint:
Common regulatory mechanisms. Cell Cycle 2011, 10, 912–915. [CrossRef] [PubMed]
96. Gomez-Escoda, B.; Ivanova, T.; Calvo, I.A.; Alves-Rodrigues, I.; Hidalgo, E.; Ayte, J. Yox1 links MBF-dependent
transcription to completion of DNA synthesis. EMBO Rep 2011, 12, 84–89. [CrossRef] [PubMed]
97. Ivanova, T.; Alves-Rodrigues, I.; Gómez-Escoda, B.; Dutta, C.; DeCaprio, J.A.; Rhind, N.; Hidalgo, E.;
Ayté, J. The DNA damage and the DNA replication checkpoints converge at the MBF transcription factor.
Mol. Biol. Cell 2013, 24, 3350–3357. [CrossRef] [PubMed]
98. Inoue, Y.; Kitagawa, M.; Taya, Y. Phosphorylation of pRB at Ser612 by Chk1/2 leads to a complex between
pRB and E2F-1 after DNA damage. EMBO J. 2007, 26, 2083–2093. [CrossRef]
99. Travesa, A.; Kuo, D.; de Bruin, R.A.M.; Kalashnikova, T.I.; Guaderrama, M.; Thai, K.; Aslanian, A.;
Smolka, M.B.; Yates, J.R.; Ideker, T.; et al. DNA replication stress differentially regulates G1/S genes via
Rad53-dependent inactivation of Nrm1. EMBO J. 2012, 31, 1811–1822. [CrossRef] [PubMed]
100. Bastos de Oliveira, F.M.; Harris, M.R.; Brazauskas, P.; de Bruin, R.A.; Smolka, M.B. Linking DNA replication
checkpoint to MBF cell-cycle transcription reveals a distinct class of G1/S genes. EMBO J. 2012, 31, 1798–1810.
[CrossRef] [PubMed]
101. Bertoli, C.; Klier, S.; McGowan, C.; Wittenberg, C.; de Bruin, R.A.M. Chk1 inhibits E2F6 repressor function in
response to replication stress to maintain cell-cycle transcription. Curr. Biol. 2013, 23, 1629–1637. [CrossRef]
[PubMed]
102. De Bruin, R.A.; Kalashnikova, T.I.; Chahwan, C.; McDonald, W.H.; Wohlschlegel, J.; Yates, J.; Russell, P.;
Wittenberg, C. Constraining G1-specific transcription to late G1 phase: The MBF-associated corepressor
Nrm1 acts via negative feedback. Mol. Cell 2006, 23, 483–496. [CrossRef] [PubMed]
103. Tercero, A.; Longhese, M.P.; Diffley, J.F.X. A Central Role for DNA Replication Forks in Checkpoint Activation
and Response. Mol. Cell 2003, 11, 1323–1336. [CrossRef]
104. Bertoli, C.; Herlihy, A.E.; Pennycook, B.R.; Kriston-Vizi, J.; de Bruin, R.A.M. Sustained E2F-Dependent
Transcription Is a Key Mechanism to Prevent Replication-Stress-Induced DNA Damage. Cell Rep. 2016, 15,
1412–1422. [CrossRef] [PubMed]
105. Ishida, S.; Huang, E.; Zuzan, H.; Spang, R.; Leone, G.; West, M.; Nevins, J.R. Role for E2F in Control of Both
DNA Replication and Mitotic Functions as Revealed from DNA Microarray Analysis. Mol. Cell. Biol. 2001,
21, 4684–4699. [CrossRef] [PubMed]
106. Tsantoulis, P.K.; Gorgoulis, V.G. Involvement of E2F transcription factor family in cancer. Eur. J. Cancer 2005,
41, 2403–2414. [CrossRef] [PubMed]
107. Stevens, C.; La Thangue, N.B. E2F and cell cycle control: A double-edged sword. Arch. Biochem. Biophys.
2003, 412, 157–169. [CrossRef]
108. De Nadal, E.; Ammerer, G.; Posas, F. Controlling gene expression in response to stress. Nat. Rev. Genet. 2011,
12, 833–845. [CrossRef] [PubMed]
Genes 2017, 8, 92 15 of 15
109. Lopez-Contreras, A.J.; Gutierrez-Martinez, P.; Specks, J.; Rodrigo-Perez, S.; Fernandez-Capetillo, O. An extra
allele of Chk1 limits oncogene-induced replicative stress and promotes transformation. J. Exp. Med. 2012,
209, 455–461. [CrossRef] [PubMed]
110. Lopez-Contreras, A.J.; Specks, J.; Barlow, J.H.; Ambrogio, C.; Desler, C.; Vikingsson, S.; Rodrigo-Perez, S.;
Green, H.; Rasmussen, L.J.; Murga, M.; et al. Increased Rrm2 gene dosage reduces fragile site breakage and
prolongs survival of ATR mutant mice. Genes Dev. 2015, 29, 690–695. [CrossRef] [PubMed]
111. Teixeira, L.K.; Wang, X.; Li, Y.; Ekholm-Reed, S.; Wu, X.; Wang, P.; Reed, S.I. Cyclin E Deregulation Promotes
Loss of Specific Genomic Regions. Curr. Biol. 2015, 25, 1327–1333. [CrossRef] [PubMed]
112. Huang, M.; Zhou, Z.; Elledge, S.J. The DNA replication and damage checkpoint pathways induce
transcription by inhibition of the Crt1 repressor. Cell 1998, 94, 595–605. [CrossRef]
113. Lubelsky, Y.; Reuven, N.; Shaul, Y. Autorepression of Rfx1 Gene Expression: Functional Conservation from
Yeast to Humans in Response to DNA Replication Arrest. Mol. Cell. Biol. 2005, 25, 10665–10673. [CrossRef]
[PubMed]
114. Håkansson, P.; Hofer, A.; Thelander, L. Regulation of mammalian ribonucleotide reduction and dNTP pools
after DNA damage and in resting cells. J. Biol. Chem. 2006, 281, 7834–7841. [CrossRef] [PubMed]
115. Shinagawa, H. SOS response as an adaptive response to DNA damage in prokaryotes. In Stress-Inducible
Cellular Responses; Feige, U., Yahara, I., Morimoto, R.I., Polla, B.S., Eds.; Birkhäuser Basel: Basel, Switzerland,
1996; pp. 221–235.
116. Haupt, Y.; Maya, R.; Kazaz, A.; Oren, M. Mdm2 promotes the rapid degradation of p53. Nature 1997, 387,
296–299. [CrossRef] [PubMed]
117. Kubbutat, M.H.G.; Jones, S.N.; Vousden, K.H. Regulation of p53 stability by Mdm2. Nature 1997, 387, 299–303.
[CrossRef] [PubMed]
118. Caetano, C.; Limbo, O.; Farmer, S.; Klier, S.; Dovey, C.; Russell, P.; de Bruin, R.A.M. Tolerance of Deregulated
G1/S Transcription Depends on Critical G1/S Regulon Genes to Prevent Catastrophic Genome Instability.
Cell Rep. 2014, 9, 2279–2289. [CrossRef] [PubMed]
119. Park, C.; Suh, Y.; Cuervo, A.M. Regulated degradation of Chk1 by chaperone-mediated autophagy in
response to DNA damage. Nat. Commun. 2015, 6, 6823. [CrossRef] [PubMed]
120. Zhang, Y.-W.; Otterness, D.M.; Chiang, G.G.; Xie, W.; Liu, Y.-C.; Mercurio, F.; Abraham, R.T. Genotoxic stress
targets human Chk1 for degradation by the ubiquitin-proteasome pathway. Mol. Cell 2005, 19, 607–618.
[CrossRef] [PubMed]
121. Bartek, J.; Lukas, J. DNA damage checkpoints: From initiation to recovery or adaptation. Curr. Opin. Cell Biol.
2007, 19, 238–245. [CrossRef] [PubMed]
122. Peschiaroli, A.; Dorrello, N.V.; Guardavaccaro, D.; Venere, M.; Halazonetis, T.; Sherman, N.E.; Pagano, M.
SCFβTrCP-Mediated Degradation of Claspin Regulates Recovery from the DNA Replication Checkpoint
Response. Mol. Cell 2006, 23, 319–329. [CrossRef] [PubMed]
123. Mailand, N.; Bekker-Jensen, S.; Bartek, J.; Lukas, J. Destruction of Claspin by SCFβTrCP Restrains Chk1
Activation and Facilitates Recovery from Genotoxic Stress. Mol. Cell 2006, 23, 307–318. [CrossRef] [PubMed]
124. Lu, X.; Nannenga, B.; Donehower, L.A. PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle
checkpoints. Genes Dev. 2005, 19, 1162–1174. [CrossRef] [PubMed]
125. Szyjka, S.J.; Aparicio, J.G.; Viggiani, C.J.; Knott, S.; Xu, W.; Tavaré, S.; Aparicio, O.M. Rad53 regulates
replication fork restart after DNA damage in Saccharomyces cerevisiae. Genes Dev. 2008, 22, 1906–1920.
[CrossRef] [PubMed]
126. Sherr, C.J.; McCormick, F. The RB and p53 pathways in cancer. Cancer Cell 2002, 2, 103–112. [CrossRef]
127. Herlihy, A.E. The DNA Replication Stress Checkpoint Transcriptional Response and Its Role in Replication
Stress Tolerance. Ph.D. Thesis, University College London, London, UK, 2017.
© 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
